The expressed TTV-ORF2 protein can be successfully used as an antigen in immunoassays to detect anti-TTV antibodies in human sera, correlating perfectly with TTV-DNA positivity.
Answers are grounded in this paper and cite their sources.
TTV-ORF2 enables anti-TTV immunoassays; extends molecular diagnostics yet leaves clinical utility open.
The present study describes the cloning and expression of ORF-2 region of TTV genome and the use of expressed peptide in developing immunoassay for detection of anti-TTV antibodies in serum. Presence of TTV-DNA in serum was detected by PCR amplifying N-22 region of ORF-1 of TTV genome. This was followed by genotyping of TTV by RFLP using N-22 amplicon. Using genotype-1 positive serum as the source of TTV, the ORF-2 region was amplified by PCR and subsequently cloned and expressed in pET-19b vector. The expressed protein, identified as 20 kDa protein on SDS-PAGE gel, was purified by affinity chromatography and then used as antigen to develop western blot assay for detection of anti-TTV antibodies in serum. Analysis of sera for anti-TTV antibodies and their comparison with presence of TTV-DNA, produced encouraging results. There was a good relation between presence of anti-TTV and TTV-DNA in these sera samples. Anti-TTV antibodies could be detected in all TTV-DNA positive sera irrespective of the presence of TTV-genotype. This investigation demonstrates that ORF-2 peptide may be used in developing immunoassay for identification of TTV infection.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: